J&J Gets FDA Nod for Plaque Psoriasis Pill Positioned to Compete With Injectables

FDA approval of Icotyde covers the treatment of adults and adolescents with moderate-to-severe plaque psoriasis. This once-daily pill, developed by partners Johnson & Johnson and Protagonist Therapeutics, offers an easier dosing option compared to injectables and is projected to become a blockbuster seller across several immunological indications. The post J&J Gets FDA Nod for Plaque…

Read More

The Dartboard Toss and the Algorithm

By GEORGE BEAUREGARD How A.I. could have personalized my 2005 cancer journey I don’t think I’m in the minority of Baby Boomer physicians when it comes to my curiosity and ambivalence about the progressing application of A.I. in medicine. But that curiosity isn’t just prospective, it’s retrospective too. In 2005, I became an outlier who…

Read More

We Should Write a Really Stern Letter

By KIM BELLARD On the heels of the disastrous floods in Texas, days away from the Hurricane Katrina twenty year anniversary, and with Hurricane Erin almost becoming another Hurricane Sandy, the dedicated employees at FEMA are worried. Very worried. They’ve got a President who repeatedly has called to dismantle the agency, a DHS Secretary who…

Read More

We’ve Never Seen Health Care Cuts This Big

In this July 1 column for The New York Times Opinion section, KFF Executive Vice President for Health Policy Larry Levitt explains how the budget reconciliation bill passed by the Senate on July 1 is effectively a partial repeal of the Affordable Care Act (ACA) and, if signed into law, the resulting reductions in Medicaid…More

Read More

Two Chairs Expands Mental Health Services to 19 More States

Two Chairs, which offers hybrid behavioral health care, expanded its presence from three states to 22 states. This expansion gives millions of people access to therapy services, as Two Chairs’ services are now available to 75% of the U.S. population. The post Two Chairs Expands Mental Health Services to 19 More States appeared first on…

Read More